| scholarly article | Q13442814 |
| P356 | DOI | 10.1677/JME-08-0076 |
| P698 | PubMed publication ID | 18984771 |
| P50 | author | Isabelle Treilleux | Q114340573 |
| P2093 | author name string | Ivan Bieche | |
| Rosette Lidereau | |||
| Charles Dumontet | |||
| Frédérique Spyratos | |||
| Pascale A Cohen | |||
| Julie A Vendrell | |||
| Sandra E Ghayad | |||
| P433 | issue | 2 | |
| P304 | page(s) | 87-103 | |
| P577 | publication date | 2008-11-04 | |
| P1433 | published in | Journal of Molecular Endocrinology | Q15716709 |
| P1476 | title | Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer | |
| P478 | volume | 42 |
| Q35380142 | Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions |
| Q24609211 | CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone |
| Q36010515 | CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis |
| Q36853431 | Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinoma |
| Q33715865 | Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer |
| Q37321759 | Dual roles of CCN proteins in breast cancer progression |
| Q37600658 | Evaluation of Bax and Bak gene mutations and expression in breast cancer |
| Q26782717 | Functions of Aurora kinase C in meiosis and cancer |
| Q28482521 | Genomic alterations in breast cancer patients in betel quid and non betel quid chewers |
| Q98467036 | Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods |
| Q36624053 | Identification of potential therapeutic targets for lung cancer by bioinformatics analysis |
| Q49483643 | Interleukin-6/signal transducer and activator of transcription 3 promotes prostate cancer resistance to androgen deprivation therapy via regulating pituitary tumor transforming gene 1 expression. |
| Q34790668 | Key genes for modulating information flow play a temporal role as breast tumor coexpression networks are dynamically rewired by letrozole |
| Q39172020 | Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibit |
| Q98771864 | Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications |
| Q47193672 | Optimizing prognosis-related key miRNA-target interactions responsible for cancer metastasis |
| Q28476617 | PTTG1 attenuates drug-induced cellular senescence |
| Q37815569 | Pituitary tumor-transforming gene and its binding factor in endocrine cancer |
| Q38915852 | Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer |
| Q54316753 | Prognosis significance of HER2 status and TACC1 expression in patients with gastric carcinoma. |
| Q47095948 | Prognostic genes of breast cancer revealed by gene co-expression network analysis |
| Q52880311 | Prognostic implications of securin expression and sub-cellular localization in human breast cancer. |
| Q38108262 | Prognostic value of survivin expression in breast cancer patients: a meta-analysis |
| Q38956004 | Pttg1 inhibits TGFβ signaling in breast cancer cells to promote their growth |
| Q37370796 | RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells |
| Q37345354 | Securin promotes the identification of favourable outcome in invasive breast cancer |
| Q37148953 | TACC2 (transforming acidic coiled-coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation |
| Q28254386 | Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets |
| Q48523042 | Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib. |
| Q38944944 | The CpG island methylator phenotype in breast cancer is associated with the lobular subtype |
| Q34446269 | The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells. |
| Q33524554 | The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR. |
| Q34031000 | hsa-mir-30c promotes the invasive phenotype of metastatic breast cancer cells by targeting NOV/CCN3. |
| Q96155603 | microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer |
| Q39096715 | p53 acts as a safeguard of translational control by regulating fibrillarin and rRNA methylation in cancer. |
Search more.